Euro area vs Serbia: Prevalence of current tobacco use
Prevalence of current tobacco use over time
- Euro area
- Serbia
How they compare
Serbia currently reports 39.7% against 26.1% in Euro area, a difference of 13.6%.
That makes Serbia's figure about 1.5 times Euro area's.
Across all 9 years both countries report, Serbia has been ahead every year.
Euro area ranks 4th and Serbia ranks 4th of 46 groups.
Serbia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Euro area | Serbia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 32.5% | 41.3% | 8.8% | Serbia |
| 2010s | 29.4% | 40.4% | 10.9% | Serbia |
| 2020s | 26.6% | 39.7% | 13.1% | Serbia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of current tobacco use, Euro area or Serbia?
- Serbia, at 39.7% against 26.1% in Euro area as of 2024.
- What is the difference in prevalence of current tobacco use between Euro area and Serbia?
- 13.6%, with Serbia ahead.
- How many years of comparable data are there for Euro area and Serbia?
- 9 years are reported by both, from 2000 to 2024.
- How do Euro area and Serbia rank globally for prevalence of current tobacco use?
- Euro area ranks 4th and Serbia ranks 4th of 46 groups.
- Where does this data come from?
- Global Health Observatory Data Repository, World Health Organization (WHO), published as Prevalence of current tobacco use (% of adults). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of the population ages 15 years and over who currently use any tobacco product (smoked and/or smokeless tobacco) on a daily or non-daily basis. Tobacco products include cigarettes, pipes, cigars, cigarillos, waterpipes (hookah, shisha), bidis, kretek, heated tobacco products, and all forms of smokeless (oral and nasal) tobacco. Tobacco products exclude e-cigarettes (which do not contain tobacco), “e-cigars”, “e-hookahs”, JUUL and “e-pipes”. The rates are age-standardized to the WHO Standard Population.